Acknowledging this connection is vital for healthcare providers as it highlights the necessity of regular screening and focused treatment of anemia in older heart failure patients, individualized treatment (such as iron supplementation and erythropoietin therapy), and collaborative care for this at-risk population. This evidence concerns the gene EPO and anemia.